Hims & Hers, one of the most popular telehealth services in the world, is in danger of losing one of its central revenue sources. The U.S. Food and Drug Administration (FDA) removed semaglutide ...
This could lead to lower sales for companies like Hims & Hers Health, which sell weight-loss medications through their ...
Hosted on MSN25m
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs ShortageHims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss and diabetes drugs has been resolved. The FDA website indicated that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback